ConductScience.org, home

Paper · 42911976

Multi-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns based upon clinico-genomic status.

Qian J and 10 others. PLoS Genet, 2026.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Multi-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns based upon clinico-genomic status. Papers, record 42911976. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42911976

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Multi-omics analysis of high-grade serous ovarian cancers reveals heterogeneity and distinct immunological patterns based upon clinico-genomic status.
Journal
PLoS Genet
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-11-02

Source PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Qian JJinghttps://orcid.org/0009-0008-7026-9386
2Bassiouni RRaniahttps://orcid.org/0000-0002-4754-9311
3Jin YYuxinhttps://orcid.org/0000-0002-6124-9681
4Rajpara SSeeta
5Neuman MMonica
6Khetan VUVarun Uhttps://orcid.org/0000-0003-2825-2157
7Salhia BBodour
8Craig DWDavid Whttps://orcid.org/0000-0003-2040-1955
9Carlson JWJoseph Whttps://orcid.org/0000-0002-3006-4107
10Roman LDLynda D

1 to 10 of 11Source PubMed

See all 11 authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ovarian NeoplasmsMajor topic
Cystadenocarcinoma, SerousMajor topic
Humans
Female
Tumor Microenvironment
Mutation
Multiomics
BRCA2 Protein
BRCA1 Protein
Exome Sequencing
Gene Expression Regulation, Neoplastic
Genomics
Spatial Transcriptomics
Receptors, CXCR4
Transcriptome

Source PubMed

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P30 CA014089NCI NIH HHSUnited StatesP30CA014089PubMed

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References63

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125,319,062Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data.Ann Oncol2015https://conductscience.org/library/papers/25319062PubMed
235,196,078Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer.Sci Adv2022https://conductscience.org/library/papers/35196078PubMed
339,311,702At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable Targets.Clin Cancer Res2024https://conductscience.org/library/papers/39311702PubMed
431,870,423Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression.Genome Biol2019https://conductscience.org/library/papers/31870423PubMed
538,705,759Lipid-associated macrophages between aggravation and alleviation of metabolic diseases.Trends Endocrinol Metab2024https://conductscience.org/library/papers/38705759PubMed
616,199,517Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.Proc Natl Acad Sci U S A2005https://conductscience.org/library/papers/16199517PubMed
720,182,602TP53 mutations in human cancers: origins, consequences, and clinical use.Cold Spring Harb Perspect Biol2010https://conductscience.org/library/papers/20182602PubMed
830,345,884Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.N Engl J Med2018https://conductscience.org/library/papers/30345884PubMed
923,945,592Signatures of mutational processes in human cancer.Nature2013https://conductscience.org/library/papers/23945592PubMed
1041,411,622Integrated Spatial Analysis Reveals the Molecular Landscape of Ovarian Precancerous Lesions.Cancer Res2026https://conductscience.org/library/papers/41411622PubMed

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42911976

GET https://conductscience.org/api/papers/v1/42911976/references?page=2